|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 31/335 | (2006.01) |
| A61K 31/7048 | (2006.01) | ||
| A61K 31/365 | (2006.01) | ||
| A61P 1/12 | (2006.01) | ||
| A61K 45/06 | (2006.01) |
| (11) | Number of the document | 2305245 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10075450.6 |
| Date of filing the European patent application | 2005-05-13 | |
| (97) | Date of publication of the European application | 2011-04-06 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-02 |
| (46) | Date of publication of the claims translation | 2019-03-12 |
| (30) | Number | Date | Country code |
| 570697 P | 2004-05-14 | US |
| (72) |
Shue, Youe-Kong, US
Babakhani, Farah Kondori, US
Okumu, Franklin W., US
Sears, Pamela Suzanne, US
Miller-Shangle, Starr Louise, US
Walsh, Robert Brian, US
|
| (73) |
Merck Sharp & Dohme LLC,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Su antibiotikų vartojimu susijusių ligų gydymas |
| Treatment of diseases associated with the use of antibiotics |
| Payment date | Validity (years) | Amount | |
| 2024-04-16 | 347.00 EUR |